MedTrace Logo

Bulkamid Treatment of Stress Incontinence in Women With Urinary Stress Incontinence and Not Suitable to TVT-procedure

NCT00984958 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-08-30

No results posted yet for this study

Summary

The aim of this prospective, randomized study of Bulkamid treatment is to investigate the efficacy of Bulkamid treatment in women with urinary stress incontinence not suitable to TVT-procedure because of suspected ISD.

Conditions

  • Urinary Stress Incontinence
  • Treatment

Interventions

DEVICE

Bulkamid

injection of Bulkamid in the urethra

DEVICE

Bulkamid expectation

expectance

Sponsors & Collaborators

  • Skaraborg Hospital

    lead OTHER_GOV

Principal Investigators

  • P-G Larsson, professor · Departm Ob/Gyn Kärnsjukhuset, 541 85 SKövde, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2015-07-31
Completion
2016-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00984958 on ClinicalTrials.gov